Industry leaders from GSK, Medidata, THREAD Research and Validic™ led an interactive discussion on virtual health research at SXSW 2017.
Julian Jenkins, Vice President and Head of Innovation, Performance and Technology at GSK kicked off the interactive panel with a twitter poll of the audience.
#SXSW audience: What #mHealth benefit do you think is most important to patients?
— GSK US (@GSKUS) March 13, 2017
#SXSW audience: Why do you think digital clinical trials are important for the future of health research? #mHealth
— GSK US (@GSKUS) March 13, 2017
#SXSW audience: What do you think is the most important measurement that is improved w/ #mHealth trials vs. traditional clinical trials?
— GSK US (@GSKUS) March 13, 2017
The panel of industry experts then delved into the following topics:
1. Could differences in access to technology and the digital divide negatively affect the demographics of clinical research or available medical care?
2. Are we prepared to radically change medicine discovery with the real-time exchange of information between patients and researchers?
3. Will virtual trials improve medical research and care or dehumanize it and jeopardize privacy?
You can view the panel on-demand here:
Interested in learning more about how digital health devices and data impact clinical trials? Download our complimentary research report: 2016 Global Pharma Survey on Digital Health